Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 1, 2003, Pages 26-33

  Washio, Takuo ^a   Kohsaka, Kazuhiro ^a   Arisawa, Hirohiko ^a   Masunaga, Hiroaki ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

CAS 153504 70 2; Cevimeline; SNI 2011, dog, metabolism, pharmacokinetics, rat

Indexed keywords

CEVIMELINE; CYTOCHROME P450; DIMETHYLANILINE MONOOXYGENASE; DRUG METABOLITE; MUSCARINIC AGENT; PROADIFEN; QUINIDINE; SNI 2011; SULFAPHENAZOLE; THIOUREA; TROLEANDOMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; FEMALE; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN; OXIDATION; RAT; SEX DIFFERENCE; SJOEGREN SYNDROME; SPECIES DIFFERENCE;

EID: 0037243765     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297066     Document Type: Article

References (19)

1. Mizobe, F., Nakahara, N., Ogane, N. et al., in: Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Disease, T. Nagatsu, A. Fisher, M. Yoshida (eds.), pp. 351-358. Plenum Press, New York (1990)
2. Bloch, K. J., Buchanan, W. W., Wohl, M. J. et al., A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore) 71, 386 (1992)
3. Dreizen, S., Brown, L. R., Daly, T. E. et al., Prevention of xerostomia-related dental caries in iarradiated cancer patients. J. Dent. Res. 56, 99 (1977)
4. Pyykönen, H., Malmström, M., Oikarinen, V. J. et al., Late effects of radiation treatment of tongue and floor-of-mouth cancer on the dentition, saliva secretion, mucous membranes and the lower jaw. Int. J. Oral Maxillofac. Surg. 15, 401 (1986)
5. Valdez, I. H., Atkinson, J. C., Ship, J. A. et al., Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry. Int. J. Radiat. Oncol. Biol. Phys. 25, 41 (1993)
6. Mandel, I. D., The functions of saliva. J. Dent. Res. 66, 623 (1987)
7. Sreebny, L. M., Valdini, A., Xerostomia: A neglected symptom. Arch. Intern. Med. 147, 1333 (1987)
8. Peters, N. L., Snipping the thread of life: Antimuscarinic side effects of medications in the elderly. Arch. Intern. Med. 149, 2414 (1989)
9. Lowry, O. H., Rosebrough, N. J., Farr, A. L. et al., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
10. Correia, M. A., in: Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed., Ortiz, P. R. De Montellano (eds.), pp. 85-117. Plenum Press, New York (1995)
11. Kobayashi, S., Murry, S., Watson, D. et al., The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem. Pharmacol. 38, 2795 (1989)
12. Wrighton, S. A., Maurel, P., Schuetz, E. G. et al., Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry 24, 2171 (1985)
13. Kato, R., Takanaka, A., Takayanaghi, M., Studies on mechanism of sex difference in drug-metabolizing activity of liver microsomes. Jpn. J. Pharmacol. 18, 482 (1968)
14. Kulkarni, A. P., Hodgson, E., Metabolism of insecticides by mixed function oxidase systems. Pharmacol. Ther. 8, 379 (1980)
15. Ziegler, D. M., Flavin-containing monooxygenases: Catalytic mechanism and substrate specificities. Drug. Metab. Rev. 19, 1 (1988)
16. Nelson, D. R., Koymans, L., Kamataki, T. et al., P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1 (1996)
17. Lawton, M. P., Cashman, J. R., Cresteil, T. et al., A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch. Biochem. Biophys. 308, 254 (1994)
18. Kawaji, A., Ohara, K., Takabatake, E., An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation. Anal. Biochem. 214, 409 (1993)
19. Waxman, D. J., Azaroff, L., Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 281, 577 (1992)